Transactions: Healthcare
Filter
Directed share issue in Oncopeptides AB (SE) — SEK 436 million
Sale of Livio AB (SE) to GeneraLife, owned by KKR (US) – Amount not disclosed
Introduction of A- and B-share class structure in H. Lundbeck A/S and subsequent A- for B-share exchange offer to eligible shareholders by the Lundbeck Foundation
Acquistion of Respiratory Motion Inc (US) by Senzime AB (SE) – Amount not disclosed
Directed share issue in Senzime AB (SE) — SEK 100 million
Private placement in Cinclus Pharma Holding AB (SE) – SEK 241 million
Private placement of shares in A3P Biomedical AB (SE) – SEK 400 million
Rights issue in Coala-Life Group AB — SEK 150 million
Fully underwritten rights issue rights issue in Observe Medical ASA (NO) — NOK 180 million
Directed share issue in SyntheticMR AB — SEK 60 million
Private placement in Hjemmelegene AS (NO) — NOK 70 million
- Föregående
- 1
- 2
- 3
- …
- 28
- Nästa